Dear Editor, In a recent issue of Tumor Biology, Guangjun Jiao Wen and his workmates published an article [1] entitled "Prognostic significance of cyclooxygenase-2 in osteosarcoma: a meta-analysis." In this study, the investigators performed a meta-analysis to derive a precise estimate of the prognostic role of cyclooxygenase-2 (COX-2) expression in patients with osteosarcoma. The investigators concluded that osteosarcoma patients with high COX-2 expression were more closely associated with neoplasm metastasis and advanced clinical stage, and also have poor 3-year survival compared with those with low COX-2 expression. However, we have several opinions that we would like to raise to the investigators.
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Firstly, the investigators had not focused specifically on the issue of the completeness of the search strategy report for databases. They just described the retrieval strategy by using combinations of keywords such as, "osteogenic sarcoma," "COX-2," "Cyclooxygenase-2," "prognosis," "prognostic," "marker," "survival," and "metastasis." We suggest that the investigators should provide us the details of the retrieval strategy and the flowchart of selection.
Secondly, 14 studies with a total of 735 osteosarcoma patients were included into the meta-analysis. In Table 1 , the number of osteosarcoma patients in these studies [2] [3] [4] [5] [6] [7] was less than the COX-2 positive numbers, respectively. We hope that the investigators could give us a reasonable explanation.
Thirdly, the investigators did not provide us any funnel plots for the Begg's test and the Egger's test. To strengthen the credibility of the meta-analysis, the investigators should provide us all these plots.
Finally, the investigators did not follow the metaanalysis of observational studies in epidemiology (MOOSE). As a minor suggestion, by adding MOOSE checklist, some summary could make this manuscript better.
In a word, more well-designed researches with large groups of patients are needed to provide further evidence for the prognostic significance of COX-2 expression in patients with osteosarcoma. 
